{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:02:16Z","timestamp":1787508136906,"version":"build-2736575974"},"reference-count":19,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000072","name":"National Institute of Dental and Craniofacial Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000072","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","oooojournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.oooo.2012.08.001","type":"journal-article","created":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T01:30:59Z","timestamp":1349055059000},"page":"e36-e40","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Erythema multiforme major following treatment with infliximab"],"prefix":"10.1016","volume":"115","author":[{"given":"Dean","family":"Edwards","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eli","family":"Boritz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward W.","family":"Cowen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald S.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.oooo.2012.08.001_bib1","first-page":"S188","article-title":"A Norwegian DMARD register: prescriptions of DMARDs and biological agents to patients with inflammatory rheumatic diseases","volume":"23","author":"Kvien","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.oooo.2012.08.001_bib2","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/art.24001","article-title":"Efficacy and safety of infliximab in patients with ankylosing spondylitis over a two-year period","volume":"59","author":"Braun","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.oooo.2012.08.001_bib3","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1136\/gut.2008.163642","article-title":"Long-term safety of infliximab for the treatment of inflammatory bowel disease: a single-centre cohort study","volume":"58","author":"Fidder","year":"2009","journal-title":"Gut"},{"key":"10.1016\/j.oooo.2012.08.001_bib4","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/j.1365-2036.2009.04206.x","article-title":"Infliximab safety profile and long-term applicability in inflammatory bowel disease: 9-year experience in clinical practice","volume":"31","author":"Zabana","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.oooo.2012.08.001_bib5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1053\/j.gastro.2003.10.047","article-title":"The safety profile of infliximab in patients with Crohn's disease: the Mayo Clinic experience in 500 patients","volume":"126","author":"Colombel","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.oooo.2012.08.001_bib6","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.jaad.2009.04.048","article-title":"Erythema multiforme during anti-tumor necrosis factor treatment for plaque psoriasis","volume":"62","author":"Ahdout","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.oooo.2012.08.001_bib7","doi-asserted-by":"crossref","first-page":"444","DOI":"10.3748\/wjg.15.4449","article-title":"Stevens\u2013Johnson syndrome complicating adalimumab therapy in Crohn's disease","volume":"15","author":"Salama","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.oooo.2012.08.001_bib9","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1001\/archderm.135.4.439","article-title":"Oral Crohn disease: clinical characteristics and long-term follow-up of 9 cases","volume":"135","author":"Dupuy","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.oooo.2012.08.001_bib10","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00004836-199102000-00008","article-title":"Oral manifestations of Crohn's disease","volume":"13","author":"Plauth","year":"1991","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.oooo.2012.08.001_bib11","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.cden.2004.08.003","article-title":"Erythema multiforme: a review and contrast from Stevens\u2013Johnson syndrome\/toxic epidermal necrolysis","volume":"49","author":"Williams","year":"2005","journal-title":"Dent Clin North Am"},{"key":"10.1016\/j.oooo.2012.08.001_bib12","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/0030-4220(89)90299-5","article-title":"Oral erythema multiforme: clinical observations and treatment of 95 patients","volume":"67","author":"Lozada-Nur","year":"1989","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"10.1016\/j.oooo.2012.08.001_bib13","first-page":"302","article-title":"Oral erythema multiforme major: a triple case report","volume":"59","author":"Brown","year":"2011","journal-title":"Gen Dent"},{"key":"10.1016\/j.oooo.2012.08.001_bib14","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0733-8635(02)00062-1","article-title":"Oral manifestations of erythema multiforme","volume":"21","author":"Ayangco","year":"2003","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.oooo.2012.08.001_bib15","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1001\/archderm.1995.01690170041005","article-title":"Erythema multiforme with mucous membrane involvement and Stevens\u2013Johnson syndrome are clinically different disorders with distinct causes","volume":"131","author":"Assier","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.oooo.2012.08.001_bib16","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1001\/archderm.1995.01690230046008","article-title":"Clinicopathologic correlation in erythema multiforme and Stevens\u2013Johnson syndrome","volume":"131","author":"C\u00f4t\u00e9","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.oooo.2012.08.001_bib17","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/archderm.1993.01680220104023","article-title":"Clinical classification of cases of toxic epidermal necrolysis, Stevens\u2013Johnson syndrome, and erythema multiforme","volume":"129","author":"Bastuji-Garin","year":"1993","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.oooo.2012.08.001_bib18","first-page":"404","article-title":"Anti-TNF-alpha-induced psoriasis\u2014an unusual paradox","volume":"3","author":"Sharma","year":"2009","journal-title":"Gastroenterologist"},{"key":"10.1016\/j.oooo.2012.08.001_bib19","doi-asserted-by":"crossref","first-page":"119","DOI":"10.4292\/wjgpt.v1.i5.119","article-title":"Henoch\u2013Sch\u00f6nlein purpura complicating adalimumab therapy for Crohn's disease","volume":"1","author":"Rahman","year":"2010","journal-title":"World J Gastrointest Pharmacol Ther"},{"key":"10.1016\/j.oooo.2012.08.001_bib20","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/j.1440-1746.2011.06622.x","article-title":"Education and imaging: gastrointestinal: herpes simplex virus-associated erythema multiforme (HAEM) during infliximab treatment for ulcerative colitis","volume":"26","author":"Sciaudone","year":"2011","journal-title":"J Gastroenterol Hepatol"}],"container-title":["Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212440312010103?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212440312010103?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T21:56:40Z","timestamp":1761947800000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212440312010103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S2212440312010103"],"URL":"https:\/\/doi.org\/10.1016\/j.oooo.2012.08.001","relation":{},"ISSN":["2212-4403"],"issn-type":[{"value":"2212-4403","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Erythema multiforme major following treatment with infliximab","name":"articletitle","label":"Article Title"},{"value":"Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oooo.2012.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Mosby, Inc.","name":"copyright","label":"Copyright"}]}}